4.7 Article

Neuroprotective effects of Schisandrin B against transient focal cerebral ischemia in Sprague-Dawley rats

Journal

FOOD AND CHEMICAL TOXICOLOGY
Volume 50, Issue 12, Pages 4239-4245

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.fct.2012.08.047

Keywords

Schisandra; Schisandrin B; Middle cerebral artery occlusion; Microglial; Matrix metalloproteinase; Anti-inflammatory

Funding

  1. Kosin University

Ask authors/readers for more resources

Fruits of Schisandra have been traditionally used in East Asia for the treatment of dyspnea, cough, dysentery, insomnia, tonic-clonic seizures, and amnesia. Schisandrin B, a dibenzocyclooctadiene derivative isolated from Fructus Schisandrae, has been shown to produce antioxidant effect on rodent liver and heart. In the present study, we investigated the neuroprotective effects of Schisandrin B, a constituent drug of the fruit of Schisandra, against focal cerebral ischemia in rats. Schisandrin B (10, 30 mg/kg, i.p.) was twice administered 30 min before the onset of ischemia and 2 h after reperfusion. Schisandrin B 10 and 30 mg/kg treated groups showed infarct volumes reduced by 25.7% and 53.4%, respectively, 2 h after occlusion. Also, Schisandrin B treated animal treatment abrogated protein expression of TNF-alpha and IL-1 beta and degradation of MMP-2 and MMP-9 in ischemic hemispheres. These results suggest that Schisandrin B treatment provides a neuroprotective effect to rats after transient focal cerebral ischemia by inhibiting inflammation and by protecting against metalloproteinase degradation. (C) 2012 Published by Elsevier Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available